Georgia 2023-2024 Regular Session

Georgia House Bill HB860

Introduced
12/4/23  

Caption

Insurance; consumers requiring insulin; reduce out-of-pocket costs

Impact

If enacted, this legislation will significantly impact the financial burden on individuals managing diabetes, offering relief from high costs associated with insulin medications. By capping out-of-pocket expenses, the bill will enhance access to essential healthcare for those dependent on insulin, potentially leading to better health outcomes. The broader implications may prompt insurers to consider similar structures for other critical medications, thereby influencing overall healthcare costs and strategies within the state.

Summary

House Bill 860 aims to amend the Official Code of Georgia Annotated specifically regarding healthcare provisions to reduce the out-of-pocket costs associated with insulin for consumers. The bill proposes that health care insurers limit the total cost-sharing amount that a covered person is required to pay for prescription insulin. The maximum allowable cost-sharing is set not to exceed $100.00 per 30-day supply of insulin, ensuring that all covered individuals can afford the necessary medication irrespective of the type or amount prescribed.

Contention

Debate around HB 860 may arise regarding its implementation and potential unintended consequences. Critics might express concerns about the implications for health insurance companies, including how such caps could affect insurance pricing and the overall healthcare market dynamics. Additionally, ensuring compliance and monitoring the enforcement of this cost cap could be challenging, requiring robust regulatory mechanisms to ensure that insurers adhere to the new definitions and limits set forth in the bill.

Companion Bills

No companion bills found.

Previously Filed As

GA S0707

Creates the Rhode Island Individual Market Affordability Act of 2024 to help reduce out-of-pocket costs for low- and moderate-income consumers enrolled in the health insurance coverage through the Rhode Island health benefits exchange.

GA H5996

Creates the Rhode Island Individual Market Affordability Act of 2024 to help reduce out-of-pocket costs for low- and moderate-income consumers enrolled in the health insurance coverage through the Rhode Island health benefits exchange.

GA HB1214

Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit.

GA S2255

Enacts the RI individual market affordability act of 2026 to establish a program to help reduce out-of-pocket costs for low- and moderate-income consumers enrolled in individual health insurance coverage through the RI health benefits exchange.

GA H7466

Enacts the RI individual market affordability act of 2026 to establish a program to help reduce out-of-pocket costs for low- and moderate-income consumers enrolled in individual health insurance coverage through the RI health benefits exchange.

GA HF405

A bill for an act relating to insurance coverage for prescription insulin drugs.

GA SF2322

A bill for an act relating to insurance coverage for prescription insulin drugs.

GA SF209

A bill for an act relating to insurance coverage for prescription insulin drugs.

GA HF658

A bill for an act relating to insurance coverage for prescription insulin drugs.

GA SF2047

A bill for an act relating to insurance coverage for prescription insulin drugs.

Similar Bills

No similar bills found.